Loading clinical trials...

Predictive Risk Factors for Pancreatic Fistula Grade C After Pancreaticoduodenectomy | Clinical Trials | Clareo Health

UNKNOWNNCT02322424

Predictive Risk Factors for Pancreatic Fistula Grade C After Pancreaticoduodenectomy

Pancreatic fistula (PF) grade C, defined by the International Study Group of Pancreatic Fistula (ISGPF) is associated with a life-threatening complication after pancreaticoduodenectomy(PD). Therefore,...

Lead sponsor: Wakayama Medical University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

Hiroki Yamaue, M.D., PhD.

CONTACT

+81-73-441-0613 yamaue-h@wakayama-med.ac.jp

Hiroki Yamaue, M.D., PhD.

CONTACT

+81-73-441-0613 trial-jt@wakayama-med.ac.jp

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment3,000

Start dateDec 2014

Last updatedDec 23, 2014

Locations shown

Chang Gun Memorial Hospital

Linkou District

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 23, 2014Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions